Mirae Asset Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8689 Cr | ₹2770 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 02 Jul 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 15% |
| Expense Ratio | 1.81 | 1.93 |
| Manager | Sailesh Raj Bhan | Vrijesh Kasera |
| ISIN Code | INF204K01968 | INF769K01EA2 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Month | 3.03% | 3.77% |
| 6 Month | 13.37% | 16.48% |
| 1 Year | 36.31% | 40.52% |
| 3 Year | 20.52% | 19.46% |
| 5 Year | 27.7% | 28.76% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 26.5% | 31.5% |
| 3 Year | 30.42% | 30.17% |
| 5 Year | 25.06% | 25.11% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Year | 17.79% | 23.48% |
| 3 Year | 20.87% | 20.47% |
| 5 Year | 20.18% | 23.92% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.65% |
| Sharp | 0.68% | 0.62% |
| Beta | 0.91% | 0.95% |
| Alpha | 1.57% | 0.72% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Vrijesh Kasera |
| Total AUM | ₹96086 Cr | ₹12061 Cr |
| Fund Manage | 5 | 4 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 4.4 | 0.92 |
| Large Cap | 45.96 | 43.94 |
| Mid Cap | 27.12 | 34.94 |
| Small Cap | 22.52 | 20.21 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 4.4 | 0.92 |
| Pharmaceuticals & Biotechnology | 75.86 | 81.65 |
| Healthcare Services | 17.38 | 16.07 |
| Retailing | 2.36 | - |
| Chemicals & Petrochemicals | - | 1.37 |
Top Comparisons
BANDHAN Focused Equity Fund - Regular Plan - Growth
3Y Returns15.17%
Canara Robeco Focused Equity Fund - Regular Plan - Growth Option
3Y Returns16.74%
Franklin India Focused Equity Fund - Growth Plan
3Y Returns17.75%
HSBC Focused Fund - Regular Growth
3Y Returns16.9%
Templeton India Equity Income Fund-Growth Plan
3Y Returns19.52%
UTI-Dividend Yield Fund.-Growth
3Y Returns17.92%
UTI Healthcare Fund - Regular Plan - Growth Option
3Y Returns21.78%
Quant Healthcare Fund Regular - Growth
3Y Returns0%